Affimed N.V. (NASDAQ:AFMD) Q3 2023 Earnings Call Transcript

Affimed N.V. (NASDAQ:AFMD) Q3 2023 Earnings Call Transcript

Affimed N.V. (NASDAQ:AFMD) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good day, everyone, and welcome to Affimed N.V. Third Quarter 2023 Earnings and Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. [Operator Instructions]. Please be advised that today’s […]

Related Keywords

Andreas Harstrick , Angus Smith , Adi Hoess , Yago Nieto , Genentech , Md Anderson Cancer Center , Most Valuable Healthcare Companies , International Accounting Standards Board , Fast Track , Cancer Center , Valuable Healthcare Companies , Productivity Growth , Technical Difficulty , Affimed , Hodgkin 39s Lymphoma , Forward Looking Statements , Fda , Chief Medical Officer ,

© 2025 Vimarsana